SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-020842
Filing Date
2023-05-11
Accepted
2023-05-11 07:31:06
Documents
66
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q grtx-20230331.htm   iXBRL 10-Q 1666868
2 EX-4.1 grtx-ex4_1.htm EX-4 221262
3 EX-10.1 grtx-ex10_1.htm EX-10 67727
4 EX-10.2 grtx-ex10_2.htm EX-10 404245
5 EX-10.3 grtx-ex10_3.htm EX-10 496817
6 EX-31.1 grtx-ex31_1.htm EX-31 18929
7 EX-31.2 grtx-ex31_2.htm EX-31 21876
8 EX-32.1 grtx-ex32_1.htm EX-32 10577
9 EX-32.2 grtx-ex32_2.htm EX-32 9349
  Complete submission text file 0000950170-23-020842.txt   7698627

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grtx-20230331.xsd EX-101.SCH 40058
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT grtx-20230331_cal.xml EX-101.CAL 36006
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grtx-20230331_pre.xml EX-101.PRE 240548
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grtx-20230331_lab.xml EX-101.LAB 354092
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT grtx-20230331_def.xml EX-101.DEF 106905
60 EXTRACTED XBRL INSTANCE DOCUMENT grtx-20230331_htm.xml XML 1171868
Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39114 | Film No.: 23908839
SIC: 2834 Pharmaceutical Preparations